Biotech Under Pressure: Why Proposed Federal Science Cuts Will Reshape Innovation More Than Any Market Cycle
The proposed removal of approximately $16.6 billion from science, research, public health, and innovation funding is often discussed as a policy issue. For biotechnology leaders, it is a structural risk issue.